HVEM network signaling in cancer
JR Šedý, P Ramezani-Rad - Advances in Cancer Research, 2019 - Elsevier
Somatic mutations in cancer cells may influence tumor growth, survival, or immune
interactions in their microenvironment. The tumor necrosis factor receptor family member …
interactions in their microenvironment. The tumor necrosis factor receptor family member …
Combination of CD 160 and CD 200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B‐cell neoplasms
JF Lesesve, S Tardy, B Frotscher… - … journal of laboratory …, 2015 - Wiley Online Library
Introduction Chronic lymphocytic leukemia is usually diagnosed through the characteristic
morphology/immunophenotype of the lymphocytes, but some CLL cases remain atypical …
morphology/immunophenotype of the lymphocytes, but some CLL cases remain atypical …
[HTML][HTML] Evaluation of CD160 and CD200 expression as differentiating markers between chronic lymphocytic leukemia and other mature B-cell neoplasms
WA El-Neanaey, RS Swelem, OM Ghallab… - … -Oncology and Stem …, 2020 - ncbi.nlm.nih.gov
Background: The present work aimed to investigate the expression of CD160/CD200 in CLL
and other mature B-cell neoplasms (MBN) and their use as an additional diagnostic tool for …
and other mature B-cell neoplasms (MBN) and their use as an additional diagnostic tool for …
Study of CD160 expression in B-chronic Lymphocytic Leukemia
A Mohammed, MM Azab - Zagazig University Medical Journal, 2022 - journals.ekb.eg
B-cell lymphoproliferative disorders (B-CLPD) are a biologically heterogeneous group of
malignant diseases characterized by accumulation of mature B lymphocytes in the bone …
malignant diseases characterized by accumulation of mature B lymphocytes in the bone …